uniQure (QURE) Net Margin (2016 - 2026)

uniQure's (QURE) quarterly Net Margin came in at 1502.95% in Q1 2026, up 128180.0% year-on-year from N/an in Q1 2025, and down 608.78% quarter-over-quarter from 295.4% in Q4 2025.

uniQure (QURE) Net Margin (2016 - 2026) Analysis & Trends

uniQure's Net Margin history runs 11 years deep, the most recent figure standing at 1502.95% for Q1 2026.

  • On a quarterly basis, Net Margin rose 128180.0% year-over-year to 1502.95% in Q1 2026; TTM through Mar 2026 was 852.43%, a 22462.0% increase from a year earlier, with the FY2025 full-year figure at 1236.0%, down 35265.0% from the prior year.
  • Net Margin declined to 1502.95% in Q1 2026 per QURE's latest filing, from 295.4% in the prior quarter.
  • Across five years, Net Margin topped out at 295.4% in Q4 2025 and bottomed at 7859.36% in Q2 2022.
  • The 5-year median for Net Margin is 1502.95% (2026), against an average of 2175.08%.
  • Biggest YoY gain for Net Margin was 654850 bps in 2022; the steepest drop was 794547 bps in 2022.
  • Year by year, Net Margin stood at 6.63% in 2022, then slumped by 16619 bps to 1094.42% in 2023, then fell by 28 bps to 1403.2% in 2024, then surged by 121 bps to 295.4% in 2025, then sank by 609 bps to 1502.95% in 2026.
  • Per Business Quant, the three latest QURE Net Margin figures stand at 1502.95% (Q1 2026), 295.4% (Q4 2025), and 2146.01% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn -1,502.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,502.95%
Dec 31, 2025 295.40%
Sep 30, 2025 -2,146.01%
Jun 30, 2025 -716.82%
Mar 31, 2025 -2,784.75%
Dec 31, 2024 -1,403.20%
Sep 30, 2024 -1,940.45%
Jun 30, 2024 -506.01%
Mar 31, 2024 -773.34%
Dec 31, 2023 -1,094.42%
Sep 30, 2023 -6,366.10%
Jun 30, 2023 -2,827.17%
Mar 31, 2023 -1,450.27%
Dec 31, 2022 6.63%
Sep 30, 2022 -3,302.76%
Jun 30, 2022 -7,859.36%
Mar 31, 2022 -2,604.80%
Dec 31, 2021 14.23%
Sep 30, 2021 -1,836.65%
Jun 30, 2021 86.12%